Accomplished physician-scientist and clinical development leader with over two decades of experience in oncology, hematology, and immuno-oncology. Proven expertise across clinical research, medical affairs, pharmacovigilance, and regulatory strategy. Led successful IND filings and early-to-late phase clinical trials, including CAR-T therapies and novel kinase inhibitors. Deep background in targeted therapy, biomarker strategy, and global trial execution. Known for cross-functional leadership, FDA engagement, and scientific innovation. Strong academic foundation with MD and PhD credentials and global experience across academic and industry settings.